Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;225(6):688-689.
doi: 10.1016/j.ajog.2021.08.025. Epub 2021 Aug 25.

Monoclonal antibody treatment of symptomatic COVID-19 in pregnancy: initial report

Affiliations

Monoclonal antibody treatment of symptomatic COVID-19 in pregnancy: initial report

Jonathan S Hirshberg et al. Am J Obstet Gynecol. 2021 Dec.
No abstract available

PubMed Disclaimer

References

    1. Dougan M., Nirula A., Azizad M., et al. Bamlanivimab plus etesevimab in mild or moderate COVID-19. N Engl J Med. 2021 [Epub ahead of print] - PMC - PubMed
    1. Zambrano L.D., Ellington S., Strid P., et al. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1641–1647. - PMC - PubMed
    1. US Food and Drug Administration Fact sheet for healthcare providers: emergency use authorization (EUA) of REGEN-COV (casirivimab and imdevimab). 2021. https://www.fda.gov/media/145611/download Available at: Accessed Aug. 8, 2021.
    1. Clements T., Rice T.F., Vamvakas G., et al. Update on transplacental transfer of IgG subclasses: impact of maternal and fetal factors. Front Immunol. 2020;11:1920. - PMC - PubMed
    1. US Food and Drug Administration Fact sheet for health care providers emergency use authorization (EUA) OF BAMLANIVIMAB. 2021. https://www.fda.gov/media/143603/download#:∼:text=High%20risk%20is%20def... Available at: Accessed Aug. 8, 2021.

Substances

LinkOut - more resources